Ranitidine hydrochloride tablet ip?

Ranitidine hydrochloride tablet IP refers to ranitidine tablets manufactured to the Indian Pharmacopoeia (IP) standards. Ranitidine is an H2 receptor antagonist used to reduce stomach acid.

Common tablet strengths:
- 150 mg per tablet
- 300 mg per tablet

Typical adult dosing (general guidance; actual dose should be prescribed by a clinician):
- 150 mg twice daily or 300 mg at bedtime for peptic ulcers or GERD, depending on severity and physician recommendation.
- Duration varies by condition (often weeks to a few months).

Important regulatory note:
- Ranitidine has faced global NDMA contamination concerns. Many regulators restricted or halted sale of ranitidine products. Availability and status vary by country and over time. Check your local regulatory authority or pharmacist for current guidance and approved alternatives (e.g., famotidine, pantoprazole).

If you’re asking for something specific (e.g., exact IP monograph details, formulation components, or current regulatory status in your country), please tell me your country and what exactly you need.